Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc > ICO response to my question

<< Previous

Bullboard Posts

Next >>

Post by Myrty1on Mar 28, 2021 6:12pm

344 Views

Post# 32895814

ICO response to my question

I sent in a short message to see what's up. They replied pretty quickly.

We will be sending out a detailed Circular to shareholders more fully describing Satellos and the transaction in the next few weeks. After you receive the Circular, let me know if you have further questions.

As to the freeze on trading--this is not our decision but rather dependent upon the TSX. The Exchange wants to make sure that investors have full information about the transaction and enough time to review.

That's about all I've got. Feel free to send some more detailed questions. I just want to get my money freed up, but I'm sure you people know the scene better than I.